Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	62422
Country	United States

Received	2021-01-08 04:59
Peer-Review Started	2021-01-08 05:00
To Make the First Decision
Return for Revision	2021-02-24 23:57
Revised	2021-03-22 05:24
Second Decision	2021-05-25 10:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-25 11:36
Articles in Press	2021-05-25 11:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-06-03 07:10
Publish the Manuscript Online	2021-06-07 11:17

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Current controversies and advances in the management of pancreatic adenocarcinoma
Manuscript Source	Invited Manuscript
All Author List	Muhammad Shehroz Zeeshan and Zeeshan Ramzan
Funding Agency and Grant Number
Corresponding Author	Zeeshan Ramzan, AGAF, FACG, Associate Professor, Gastrointestinal Section, Department of Medicine, Texas Health Harris Methodist Hospital, 1301 Pennsylvania Ave, Fort Worth, TX 76104, United States. zeeshanramzan@hotmail.com
Key Words	Pancreatic adenocarcinoma; Advances in management; Imaging; Novel approaches; Chemotherapy; Controversies
Core Tip	Early diagnosis and treatment of pancreatic adenocarcinoma has remained a challenge over the last several decades. Despite best efforts, the long-term survival rate has not significantly improved. The following manuscript highlights the current advances and controversies in the management of pancreatic cancer. The standard systemic therapies have been presented in a format that is easy to read and follow. Novel approaches in diagnosis and management have been discussed in light of evidence-based medicine.
Publish Date	2021-06-07 11:17
Citation	Zeeshan MS, Ramzan Z. Current controversies and advances in the management of pancreatic adenocarcinoma. World J Gastrointest Oncol 2021; 13(6): 472-494
URL	https://www.wjgnet.com/1948-5204/full/v13/i6/472.htm
DOI	https://dx.doi.org/10.4251/wjgo.v13.i6.472

Full Article (PDF)	WJGO-13-472.pdf
Full Article (Word)	WJGO-13-472.docx
Manuscript File	62422_Auto_Edited-JPY.docx
Answering Reviewers	62422-Answering reviewers.pdf
Audio Core Tip	62422-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	62422-Conflict-of-interest statement.pdf
Copyright License Agreement	62422-Copyright license agreement.pdf
Supplementary Material	62422-Copyright permission.pdf
Peer-review Report	62422-Peer-review(s).pdf
Scientific Misconduct Check	62422-Bing-Ma YJ-1.jpg
Scientific Misconduct Check	62422-Bing-Fan JR-2.png
Scientific Misconduct Check	62422-Scientific misconduct check.pdf
Scientific Editor Work List	62422-Scientific editor work list.pdf